Sartobind® Rapid A is a protein A membrane chromatography solution engineered for efficient antibody purification in the biopharmaceutical industry, specifically designed for capturing Fc-region containing molecules. The fully scalable portfolio provides the necessary flexibility, to accelerate process development, reduce costs and increase productivity in mAb purification.

Availability:

Overview

Sartobind^® Rapid A is a protein A membrane chromatography solution designed to increase the efficiency of antibody purification processes. This platform is well-suited for process intensification, reducing process times due to higher operational flow rates, while maintaining high binding capacities and minimizing back pressure. Altogether, Sartobind^® Rapid A has the potential to substantially reduce the cost associated with the mAb capture step, particularly in process development and production of material for early clinical phases.

Available formats:

96 Well Plates
Capsules (1.2 mL, 10 mL, 75 mL and 200 mL)
Cassette (0.8 L)

Complementary products:

Rapid A Ligand
Manifold Pilot Holder

Features and Benefits:

Time Savings – faster cycling times with membranes mean less time is required for process development and validation. Moreover, column handling operations are no longer necessary.
Cost reduction – especially for manufacturing of clinical phase material or smaller commercial scale
Risk mitigation – because membranes are less sensitive to air presence or bed instability issues the risk of production stop is less significant
Compact footprint and flexibility- smaller bed volumes can purify the same amounts of target molecules in the same amount of time. Furthermore, there is no need for ancillary equipment related to packing and maintenance.
Scalability